Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

TransUnion ha un obiettivo di prezzo di consenso pari a $99, stabilito in base alle ultime valutazioni degli analisti di 25. Le ultime 3 valutazioni degli analisti sono state rilasciate da Oppenheimer, Goldman Sachs y Needham il octubre 13, 2025, octubre 2, 2025 y septiembre 3, 2025. Con un obiettivo di prezzo medio di $97 tra le Oppenheimer, Goldman Sachs y Needham, c'è un implicito 16.20% upside per TransUnion da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/13/2025 | 11.4% | Oppenheimer | $110 → $93 | Assumes | → Outperform | |||
10/02/2025 | -0.57% | Goldman Sachs | $96 → $83 | Maintains | Neutral | |||
10/01/2025 | — | Seaport Global | — | Initiates | → Neutral | |||
09/03/2025 | 37.76% | Needham | → $115 | Upgrade | Hold → Buy | |||
07/25/2025 | 25.78% | UBS | $98 → $105 | Maintains | Neutral | |||
07/25/2025 | 41.35% | BMO Capital | $115 → $118 | Maintains | Outperform | |||
07/25/2025 | 41.35% | Wells Fargo | $124 → $118 | Maintains | Overweight | |||
07/25/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
07/10/2025 | 37.76% | BMO Capital | → $115 | Initiates | → Outperform | |||
07/08/2025 | 29.37% | Oppenheimer | $100 → $108 | Maintains | Outperform | |||
05/22/2025 | 19.79% | Oppenheimer | $96 → $100 | Maintains | Outperform | |||
04/25/2025 | 34.16% | Stifel | $120 → $112 | Maintains | Buy | |||
04/25/2025 | 15% | Oppenheimer | $93 → $96 | Maintains | Outperform | |||
04/14/2025 | 40.15% | Wells Fargo | $130 → $117 | Maintains | Overweight | |||
04/04/2025 | 1.82% | Barclays | $105 → $85 | Maintains | Equal-Weight | |||
02/14/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
02/03/2025 | 24.58% | UBS | $102 → $104 | Maintains | Neutral | |||
01/28/2025 | 52.13% | Morgan Stanley | $130 → $127 | Maintains | Overweight | |||
01/16/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/15/2025 | 37.76% | Jefferies | $125 → $115 | Maintains | Buy | |||
01/13/2025 | 22.18% | UBS | $112 → $102 | Maintains | Neutral | |||
01/10/2025 | 50.93% | Wells Fargo | $135 → $126 | Maintains | Overweight | |||
01/07/2025 | 34.16% | Oppenheimer | $115 → $112 | Maintains | Outperform | |||
12/12/2024 | 55.73% | Morgan Stanley | $119 → $130 | Maintains | Overweight | |||
11/20/2024 | 37.76% | Oppenheimer | $122 → $115 | Maintains | Outperform | |||
10/24/2024 | 34.16% | UBS | $110 → $112 | Maintains | Neutral | |||
10/24/2024 | 44.94% | RBC Capital | $121 → $121 | Reiterates | Outperform → Outperform | |||
10/24/2024 | 42.55% | Morgan Stanley | $103 → $119 | Maintains | Overweight | |||
10/24/2024 | 43.75% | Stifel | $103 → $120 | Maintains | Buy | |||
10/24/2024 | 46.14% | Oppenheimer | $118 → $122 | Maintains | Outperform | |||
10/24/2024 | 61.72% | Wells Fargo | $125 → $135 | Maintains | Overweight | |||
10/24/2024 | 55.73% | Baird | $104 → $130 | Maintains | Outperform | |||
10/24/2024 | — | Needham | — | Reiterates | → Hold | |||
10/10/2024 | 55.73% | Wolfe Research | → $130 | Upgrade | Peer Perform → Outperform | |||
10/08/2024 | 41.35% | Oppenheimer | $97 → $118 | Maintains | Outperform | |||
10/02/2024 | 30.57% | Goldman Sachs | $97 → $109 | Maintains | Neutral | |||
10/02/2024 | 49.74% | Wells Fargo | $100 → $125 | Maintains | Overweight | |||
10/01/2024 | 31.77% | UBS | → $110 | Initiates | → Neutral | |||
09/13/2024 | 25.78% | Barclays | $80 → $105 | Maintains | Equal-Weight | |||
09/12/2024 | 23.38% | Morgan Stanley | $96 → $103 | Maintains | Overweight | |||
08/20/2024 | 16.2% | Goldman Sachs | $87 → $97 | Maintains | Neutral | |||
08/12/2024 | 19.79% | Wells Fargo | → $100 | Initiates | → Overweight | |||
07/26/2024 | 16.2% | Oppenheimer | $90 → $97 | Maintains | Outperform | |||
07/26/2024 | -4.17% | Barclays | $75 → $80 | Maintains | Equal-Weight | |||
07/26/2024 | 26.98% | RBC Capital | $85 → $106 | Maintains | Outperform | |||
07/26/2024 | 24.58% | Baird | $94 → $104 | Maintains | Outperform | |||
07/26/2024 | 10.21% | Needham | $89 → $92 | Maintains | Buy | |||
07/09/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
06/20/2024 | 10.21% | B of A Securities | → $92 | Upgrade | Neutral → Buy | |||
04/26/2024 | 7.81% | Morgan Stanley | $87 → $90 | Maintains | Overweight | |||
04/26/2024 | 10.21% | Stifel | $83 → $92 | Maintains | Buy | |||
04/26/2024 | 12.6% | Baird | $87 → $94 | Maintains | Outperform | |||
04/25/2024 | 6.61% | Needham | $87 → $89 | Maintains | Buy | |||
04/09/2024 | 7.81% | Oppenheimer | $81 → $90 | Maintains | Outperform | |||
04/01/2024 | 7.81% | B of A Securities | $65 → $90 | Upgrade | Underperform → Neutral | |||
03/26/2024 | -4.17% | Evercore ISI Group | $70 → $80 | Maintains | In-Line | |||
02/14/2024 | 1.82% | RBC Capital | $85 → $85 | Reiterates | Outperform → Outperform | |||
02/14/2024 | 1.82% | Wells Fargo | $80 → $85 | Maintains | Overweight | |||
02/14/2024 | 4.22% | Baird | $80 → $87 | Maintains | Outperform | |||
02/14/2024 | 0.62% | JP Morgan | $69 → $84 | Maintains | Overweight | |||
02/14/2024 | -10.16% | Barclays | $55 → $75 | Maintains | Equal-Weight | |||
02/14/2024 | -0.57% | Stifel | $76 → $83 | Maintains | Buy | |||
02/14/2024 | -10.16% | Truist Securities | $65 → $75 | Maintains | Hold | |||
02/13/2024 | 4.22% | Needham | $75 → $87 | Maintains | Buy | |||
01/17/2024 | 1.82% | Jefferies | $75 → $85 | Maintains | Buy | |||
12/29/2023 | -13.75% | Goldman Sachs | $63 → $72 | Maintains | Neutral | |||
12/19/2023 | -2.97% | Oppenheimer | → $81 | Initiates | → Outperform | |||
11/22/2023 | -8.96% | Morgan Stanley | $70 → $76 | Maintains | Overweight | |||
11/16/2023 | -18.54% | Deutsche Bank | $57 → $68 | Maintains | Buy | |||
11/16/2023 | -23.33% | Stifel | $59 → $64 | Maintains | Buy | |||
10/31/2023 | -24.53% | Goldman Sachs | $73 → $63 | Maintains | Neutral | |||
10/30/2023 | -24.53% | Goldman Sachs | $73 → $63 | Maintains | Neutral | |||
10/26/2023 | -29.32% | Stifel | $90 → $59 | Maintains | Buy | |||
10/26/2023 | -12.55% | Goldman Sachs | $85 → $73 | Maintains | Neutral | |||
10/25/2023 | -16.15% | RBC Capital | $97 → $70 | Maintains | Outperform | |||
10/25/2023 | -34.12% | Barclays | $80 → $55 | Maintains | Equal-Weight | |||
10/25/2023 | -12.55% | Goldman Sachs | $85 → $73 | Maintains | Neutral | |||
10/25/2023 | -16.15% | Morgan Stanley | $93 → $70 | Maintains | Overweight | |||
10/25/2023 | — | Evercore ISI Group | — | Downgrade | Outperform → In-Line | |||
10/25/2023 | -47.29% | B of A Securities | $95 → $44 | Downgrade | Buy → Underperform | |||
10/24/2023 | -10.16% | Needham | $92 → $75 | Maintains | Buy | |||
10/17/2023 | -10.16% | Truist Securities | $85 → $75 | Maintains | Hold | |||
10/02/2023 | 16.2% | RBC Capital | → $97 | Reiterates | Outperform → Outperform | |||
07/26/2023 | 11.4% | Morgan Stanley | $78 → $93 | Maintains | Overweight | |||
07/26/2023 | 16.2% | RBC Capital | $84 → $97 | Maintains | Outperform | |||
07/26/2023 | 12.6% | Wells Fargo | $88 → $94 | Maintains | Overweight | |||
07/26/2023 | -4.17% | Barclays | $67 → $80 | Maintains | Equal-Weight | |||
07/25/2023 | 10.21% | Needham | $84 → $92 | Maintains | Buy | |||
07/19/2023 | 1.82% | Truist Securities | $70 → $85 | Maintains | Hold | |||
06/05/2023 | -4.17% | Goldman Sachs | $71 → $80 | Maintains | Neutral | |||
05/18/2023 | 0.62% | RBC Capital | → $84 | Reiterates | Outperform → Outperform | |||
04/26/2023 | -16.15% | Truist Securities | $66 → $70 | Maintains | Hold | |||
04/26/2023 | 0.62% | Needham | → $84 | Upgrade | Hold → Buy | |||
03/31/2023 | -19.74% | Barclays | $72 → $67 | Maintains | Equal-Weight | |||
03/22/2023 | -6.56% | Morgan Stanley | $80 → $78 | Maintains | Overweight | |||
03/01/2023 | -4.17% | Exane BNP Paribas | → $80 | Upgrade | Neutral → Outperform | |||
02/15/2023 | 0.62% | B of A Securities | $91 → $84 | Maintains | Buy | |||
02/15/2023 | -0.57% | Baird | $78 → $83 | Maintains | Outperform | |||
02/15/2023 | -16.15% | Credit Suisse | $65 → $70 | Maintains | Neutral | |||
02/15/2023 | -13.75% | Barclays | $65 → $72 | Maintains | Equal-Weight |
El último precio objetivo de TransUnion (NYSE:TRU) fue comunicado por Oppenheimer el octubre 13, 2025. La firma de analistas fijó un precio objetivo para $93.00 que espera TRU a rise dentro de 12 meses (un posible 11.40% upside). 25 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para TransUnion (NYSE:TRU) fue proporcionada por Oppenheimer, y TransUnion su outperform calificación.
La última revisión al alza de TransUnion se produjo en septiembre 3, 2025, cuando Needham elevó su precio objetivo a $115. Needham anteriormente tenía a hold para TransUnion.
La última revisión a la baja de TransUnion se produjo en octubre 25, 2023, cuando Evercore ISI Group cambió su precio objetivo de N/A a N/A para TransUnion.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de TransUnion, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de TransUnion se registró el octubre 13, 2025, por lo que la próxima calificación estará disponible en torno al octubre 13, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de TransUnion (TRU) fue un con un precio objetivo de $110.00 a $93.00. El precio actual al que cotiza TransUnion (TRU) es de $83.48, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.